Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy
Authors
Keywords
Biologics, COVID-19, SARS-CoV-2, Severe asthma
Journal
RESPIRATORY MEDICINE
Volume 177, Issue -, Pages 106287
Publisher
Elsevier BV
Online
2020-12-24
DOI
10.1016/j.rmed.2020.106287
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 and Asthma: Reflection During the Pandemic
- (2020) Shuang Liu et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
- (2020) Xiaochen Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Eosinophil responses during COVID-19 infections and coronavirus vaccination
- (2020) Andrew W. Lindsley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
- (2020) Daniel J. Jackson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Incidence of venous thromboembolism in hospitalized patients with COVID‐19
- (2020) Saskia Middeldorp et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Considerations on Biologicals for Patients with allergic disease in times of the COVID‐19 pandemic: an EAACI Statement
- (2020) Alessandra Vultaggio et al. ALLERGY
- COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments
- (2020) Enrico Heffler et al. ALLERGY
- The relationship between human coronaviruses, asthma and allergy – an unresolved dilemma
- (2020) Maciej Chałubiński et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
- (2020) Antoine Beurnier et al. EUROPEAN RESPIRATORY JOURNAL
- Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review
- (2020) Mário Morais-Almeida et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19
- (2020) Krishan D. Chhiba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Asthma Among Hospitalized Patients with COVID-19 and Related Outcomes
- (2020) Stephanie Lovinsky-Desir et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Early experiences of SARS-CoV-2 infection in severe asthmatics receiving biologic therapy
- (2020) Javier Domínguez-Ortega et al. Journal of Allergy and Clinical Immunology-In Practice
- Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
- (2020) Jee Myung Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity
- (2020) Mohsin Sheraz Mughal et al. RESPIRATORY MEDICINE
- Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control and Prevention
- (2020) Hyo‐Geun Choi et al. ALLERGY
- The emergence of new biologics for severe asthma
- (2019) Katrien AB Eger et al. CURRENT OPINION IN PHARMACOLOGY
- Characteristics and treatment regimens across ERS SHARP severe asthma registries
- (2019) Job J.M.H. van Bragt et al. EUROPEAN RESPIRATORY JOURNAL
- Consequences of long-term OCS therapy and its side effects in severe asthma in adults – A focused review of the impact data in the literature
- (2018) Timm Volmer et al. EUROPEAN RESPIRATORY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started